B13 Solution/ Drops
NDC Package 63479-0213-1
Package Information
B13 (allium sativum, avena sativa, calcarea carbonica, calcarea fluorica, calcarea phosphorica, calcarea sulphurica, carbo vegetabilis, ferrum iodatum, hypericum perforatum, kali phosphoricum, lacticum acidum, magnesia phosphorica, natrum muriaticum, natrum phosphoricum, phosphoricum acidum, urtica urens) solution/ dropses is adults & children ages 12 years and over: Take 10 drops under the tongue 3 times a day, or as directed by your healthcare professional. This formulation utilizes a solution/ drops delivery system. Marketed by Apex Energetics Inc., this product is identified by NDC 63479-0213.
Identification & Billing
Clinical Specifications
- POTASSIUM PHOSPHATE, DIBASIC 30 [hp_X]/mL
- GARLIC 1 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 30 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 20 [hp_X]/mL
- CALCIUM FLUORIDE 30 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 10 [hp_X]/mL
- SODIUM CHLORIDE 1 [hp_X]/mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 30 [hp_X]/mL
- CALCIUM SULFATE ANHYDROUS 30 [hp_X]/mL
- ACTIVATED CHARCOAL 20 [hp_X]/mL
- HYPERICUM PERFORATUM 30 [hp_X]/mL
- LACTIC ACID, DL- 30 [hp_X]/mL
- FERROUS IODIDE 200 [hp_X]/mL
- AVENA SATIVA FLOWERING TOP 30 [hp_X]/mL
- PHOSPHORIC ACID 20 [hp_X]/mL
- URTICA URENS 1 [hp_X]/mL
- Allergens - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Plant Proteins - [CS]
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 63479 - Apex Energetics Inc.
- 63479-0213 - B13
- 63479-0213-1 - 30 mL in 1 BOTTLE, GLASS
- 63479-0213 - B13
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63479-0213-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of B13 Cell Salt Complex, a human over the counter drug labeled by Apex Energetics Inc.. This solution/ drops is formulated for sublingual use and contains potassium phosphate, dibasic; garlic; oyster shell calcium carbonate, crude; magnesium phosphate, dibasic trihydrate; calcium fluoride; tribasic calcium phosphate; sodium chloride; sodium phosphate, dibasic, heptahydrate; calcium sulfate anhydrous; activated charcoal; hypericum perforatum; lactic acid, dl-; ferrous iodide; avena sativa flowering top; phosphoric acid; urtica urens as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Apex Energetics Inc. on November 01, 1994. The current certification is valid through December 31, 2026.
How is this Apex Energetics Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63479021301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.